Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-γ signaling

J Immunol. 2014 Oct 15;193(8):4149-58. doi: 10.4049/jimmunol.1400594. Epub 2014 Sep 15.

Abstract

Helicobacter pylori infection not only induces gastric inflammation but also increases the risk of gastric tumorigenesis. IFN-γ has antimicrobial effects; however, H. pylori infection elevates IFN-γ-mediated gastric inflammation and may suppress IFN-γ signaling as a strategy to avoid immune destruction through an as-yet-unknown mechanism. This study was aimed at investigating the mechanism of H. pylori-induced IFN-γ resistance. Postinfection of viable H. pylori decreased IFN-γ-activated signal transducers and activators of transcription 1 and IFN regulatory factor 1 not only in human gastric epithelial MKN45 and AZ-521 but also in human monocytic U937 cells. H. pylori caused an increase in the C-terminal tyrosine phosphorylation of Src homology-2 domain-containing phosphatase (SHP) 2. Pharmacologically and genetically inhibiting SHP2 reversed H. pylori-induced IFN-γ resistance. In contrast to a clinically isolated H. pylori strain HP238, the cytotoxin-associated gene A (CagA) isogenic mutant strain HP238(CagAm) failed to induce IFN-γ resistance, indicating that CagA regulates this effect. Notably, HP238 and HP238(CagAm) differently caused SHP2 phosphorylation; however, imaging and biochemical analyses demonstrated CagA-mediated membrane-associated binding with phosphorylated SHP2. CagA-independent generation of reactive oxygen species (ROS) contributed to H. pylori-induced SHP2 phosphorylation; however, ROS/SHP2 mediated IFN-γ resistance in a CagA-regulated manner. This finding not only provides an alternative mechanism for how CagA and ROS coregulate SHP2 activation but may also explain their roles in H. pylori-induced IFN-γ resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Bacterial / genetics
  • Antigens, Bacterial / immunology*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / immunology*
  • Carcinogenesis
  • Cell Line, Tumor
  • Gastric Mucosa / immunology
  • Gastric Mucosa / microbiology
  • Helicobacter Infections / immunology*
  • Helicobacter pylori / immunology*
  • Humans
  • Inflammation / immunology
  • Inflammation / microbiology
  • Interferon Regulatory Factor-1 / metabolism
  • Interferon-gamma / antagonists & inhibitors
  • Interferon-gamma / immunology*
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / antagonists & inhibitors
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / genetics
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / immunology*
  • RNA Interference
  • RNA, Small Interfering
  • Reactive Oxygen Species / metabolism
  • STAT1 Transcription Factor / metabolism
  • U937 Cells

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • STAT1 Transcription Factor
  • STAT1 protein, human
  • cagA protein, Helicobacter pylori
  • Interferon-gamma
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11